Divabuterol
- Level
- Commodity
- Parent
- 51391700
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51391716This classification denotes a bronchodilator, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier BVG9H4U2ZB. European Medicines Agency schedules Divabuterol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06337MIG. Divabuterol generally arises in the molecular formula C22H35NO5. The term DIVABUTEROL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 14, no. 1, 2000, list 43.) DIVABUTEROL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule divabuterol under HS 29225000 and SITC 51467. As of Q4 2014, DIVABUTEROL remains the US FDA Preferred Term for this commodity. Divabuterol bears US NLM identifiers UMLS ID C1880370 and NCI Concept Code C65446. SMILES: OC(CNC(C)(C)C)C1CC(OC(=O)C(C)(C)C)CC(OC(=O)C(C)(C)C)C1.
Same parent
Under 51391700 · 48Activities that produce or sell this
KBLI · 8Inherited from family 51390000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.